glaucoma/optic nerve diseases/neurodegenerations drug (Johns Hopkins University)

N/A

Report date: 2025/03/20 10:06:38
NME

Base Information

Drug Nameglaucoma/optic nerve diseases/neurodegenerations drug (Johns Hopkins University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationGlaucomaOptic Nerve Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesJohns Hopkins Technology VenturesJohns Hopkins University
Inactive CompaniesN/A
Active IndicationsNerve DegenerationGlaucomaOptic Nerve Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A